The first patient was recently treated in the AMELIE clinical trial during April 2026. The team at The Royal London Hospital implanted healthy muscle cells attached to microscopic beads in humans for the first time. The study aims to treat faecal incontinence caused by childbirth injury.
The first patients had been biopsied two weeks prior to this in Cardiff at the University Hospital of Wales.
These are important milestones for the progression of this groundbreaking treatment. The team looks forward to treating the remaining patients enrolled in the trial in the coming months.
English (UK) 
Italiano 
Español 
Français 
Português 
Deutsch 
Dansk